Analysts expect the firm's earnings to rise 12% this year and 26% in 2026. The post Stock Of The Day Holds Up As Insurance Stocks Keep Lofty Ranking appeared first on Investor's Business Daily.

CFG's first-quarter 2025 results are likely to reflect a decline in NII and non-interest income, along with a rise in expenses.

Synchronoss Technologies SNCR shares have returned 12.2% over the past three months, outperforming the Zacks Computer and Technology sector and the Internet - Software industry's declines of 11.6 % and 6.5%, respectively. It has also outperformed its industry peers, including Appian APPN, BlackBerry BB and Five9 FIVN.

CPT to benefit from its well-diversified portfolio, technology upgrades and a strong balance sheet, but elevated supply levels and sustained high interest rates ail.

AXIL's Q3 earnings falls despite higher revenues. Stock slumps 37% in a month as investors weigh growth plans, cost pressures and outlook.

NEW YORK CITY, NY / ACCESS Newswire / April 11, 2025 / WHY: New York, N.Y., April 11, 2025.

Amazon stock is set to break a streak of nine straight losing weeks, helped by Wednesday's rally. The post Amazon Stock Set To Break Nine-Week Skid As Wall Street Debates Tariff Hit appeared first on Investor's Business Daily.

Constellation Brands reported a drop in shipments last quarter. Transcript: Tariffs have taken a toll on the alcohol industry, but one of the biggest beer-makers in the U.S. says its sales are declining for another reason: immigration.

ST. AUGUSTINE, Fla., April 11, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced the grand opening of Estuary at Madeira , an exclusive new home community nestled along the picturesque Intracoastal Waterway in the Madeira master plan in St. Augustine, Florida. The Sales Center is now open at 620 Pantano Drive in St. Augustine.

Two days after President Donald Trump issued a 90-day pause on higher tariff rates for most countries except China, JPMorgan Chase (JPM 3.14%) CEO Jamie Dimon warned that the "economy is facing considerable turbulence," citing concerns of trade wars, persistent inflation, and fiscal deficits. In JPMorgan's first-quarter earnings call this morning, Dimon placed the odds of a recession at a 50-50 coin flip.

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 300 points on Friday.

FIVN's strong AI momentum, deepening partnerships and expanding global reach make the stock an investment-worthy contender.

JNJ's Innovative Medicines unit sales are expected to have been driven by drugs like Darzalex and Tremfya. We do not expect any improvement in MedTech sales.

ODC gains an "Outperform" rating as renewable diesel demand soars, and the Ultra Pet acquisition boosts growth, profitability and market presence.

The decline in Novavax stock follows the HHS Secretary's concerns regarding the efficacy of its protein-based COVID-19 vaccine in a recent interview.

Apple's reliance in China will likely lead to higher prices for iPhones.

USB's first-quarter 2025 earnings are expected to reflect lower NII and non-interest income. Yet, decent loan demand is likely to have offered support.

ACIW teams up with NationsBenefits to expand health and retail benefit access, unlocking growth in the booming healthcare payments space.

Companies like United Natural Foods, Sprouts Farmers and Beyond Meat are responding to the rising demand for organic and ethically sourced foods.

CoreWeave, Inc. offers an attractive near-term trade with a strong pipeline post-IPO, it's the company's one-winning round before the game is over. Post-IPO Friday, we told short enthusiasts to pay close attention to this name on our sell call; since, CRWV stock underperformed an already struggling S&P 500 by roughly 16%. The rent GPU as a service business model is structurally flawed and especially troubling for CoreWeave as it demands upfront capex while CoreWeave has high debt and increasing losses.